6 [25] B. Erbas, E. Provenzano, J. Armes, and D. Gertig, “The natural history of ductal carcinoma in situ of the breast: a review,” Breast Cancer Research and Treatment, vol. 97, no. 2, pp. 135– 144, 2006. [26] D. P. Winchester, J. M. Jeske, and R. A. Goldschmidt, “The diagnosis and management of ductal carcinoma in-situ of the breast,” CA Cancer Journal for Clinicians, vol. 50, no. 3, pp. 184–200, 2000. [27] G. L. Ottesen, H. P. Graversen, M. Blichert-Toft, I. J. Chris- tensen, and J. A. Andersen, “Carcinoma in situ of the female breast: 10 Year follow-up results of a prospective nationwide study,” Breast Cancer Research and Treatment, vol. 62, no. 3, pp. 197–210, 2000. [28] T. Greene, P. I. Tartter, S. R. Smith, and A. Estabrook, “The signﬁcance of surgical margins for patients with atypical ductal hyperplasia,” The American Journal of Surgery, vol. 192, no. 4, pp. 499–501, 2006. [29] J. M. Dixon and R. E. Mansel, “ABC of breast diseases: symptoms assessment and guidelines for referral,” British Medical Journal, vol. 309, no. 6956, pp. 722–726, 1994. [30] M. A. Chaudary, R. R. Millis, G. C. Davies, and J. L. Hayward, “Nipple discharge: the diagnostic value of testing for occult blood,” Annals of Surgery, vol. 196, no. 6, pp. 651–655, 1982. International Journal of Breast Cancer